Search filters

Filters
Clear All

Phase

  • 47
  • 38
  • 56
  • 10
  • 50
  • 4
  • 179
  • 390
  • 113
  • 11
  • 28
  • 351
  • 8
  • 382

Found 390 Neoplasms trials

A listing of Neoplasms medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Sort by:
18 years - 99 years
All genders
Phase 3
Interventional
This study investigates the effects of an investigational medication in patients with Chronic Phase Chronic Myeloid Leukemia (CP-CML). The purpose of this study is to compare the investigational medication to another treatment in patients with CP-CML who have been previously treated with other medications.Participants in this study will be assigned …
18 years or above
All genders
Phase 3
Interventional
This study investigates the use of an investigational medication in combination with standard therapies for patients with acute myeloid leukemia (AML) who have specific genetic mutations and have not yet received treatment. The purpose of this study is to assess the benefits and risks of adding the investigational medication to …
99 years or below
All genders
Please refer to Protocol Section 3 (Study Objectives). Please refer to Protocol Section 3 (Study Objectives). Please refer to Protocol Section 3 (Study Objectives).
18 years or above
All genders
Phase 2
Interventional
This study investigates a maintenance immunotherapy using CD40/Dectin-1 for patients with unresectable pancreatic ductal adenocarcinoma (PDA) who have not shown disease progression after 4-6 months of first-line chemotherapy. This research aims to explore the effectiveness of an investigational immunotherapy in maintaining disease stability in these patients.The study involves several procedures, …
18 years or above
All genders
Phase 2
Interventional
This study investigates the efficacy and safety of an investigational medication in participants with advanced Pheochromocytoma and Paraganglioma (PCPG). The purpose of this study is to evaluate the response of these tumors to the investigational medication when other treatments are not suitable or have been declined.Participants will undergo a two-stage …
18 years - 80 years
All genders
Phase 2/3
Interventional
This study investigates a treatment for adults with acute myeloid leukemia (AML) that has not responded to previous treatment or has returned after treatment. The purpose of this research is to evaluate the effectiveness and safety of an investigational medication given with Cytarabine, compared to a placebo given with Cytarabine. …
18 years or above
All genders
Phase 1
Interventional
This study investigates the investigational medication in patients with relapsed or refractory T-cell lymphoma. The purpose of this study is to understand how the medication works in the body and its effects on the disease.The study evaluates the safety and tolerability of the investigational medication. Researchers are also looking at …
18 years or above
All genders
Phase 2
Interventional
This study investigates primary central nervous system lymphoma. The purpose of this study is to evaluate the safety and efficacy of an investigational medication as a first-line treatment for individuals who cannot undergo a transplant.The study evaluates the effectiveness and safety of the investigational medication in patients. It focuses on …
18 years or above
All genders
Phase 2
Interventional
This study investigates advanced renal cell carcinoma.The study evaluates the safety and tolerability of investigational medications in patients with this condition.Who can participate: Adults aged 18 or older with a confirmed diagnosis of RCC and no prior systemic therapy for RCC may participate. Participants must have adequate organ function and …
18 years or above
All genders
Phase 2
Interventional
This study investigates the treatment of acute graft-versus-host disease (GVHD).The study evaluates the effectiveness and safety of using ruxolitinib as a treatment for GVHD.Who can participate: Adults aged 18 and older with acute GVHD after allogeneic hematopoietic cell transplant can participate. Participants must not have had prior systemic acute GVHD …
371 - 380 of 390